Phase 2 Coronary Artery Disease Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 2
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Peripheral Arterial DiseaseCoronary Artery Disease (CAD)
Sirius Therapeutics Co., Ltd.104 enrolled1 locationNCT07318155
Recruiting
Phase 1Phase 2
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Coronary Heart DiseaseCoronary Artery DiseaseAtheroscleroses
Xia Liang30 enrolled1 locationNCT07493603
Recruiting
Phase 2
YN001-004 in Patients With Coronary Atherosclerosis in Australia
Coronary Artery DiseaseCoronary Atherosclerotic Disease
Beijing Inno Medicine Co., Ltd.24 enrolled7 locationsNCT06700720
Recruiting
Phase 2
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
Coronary Artery Disease
Xijing Hospital18 enrolled1 locationNCT06572267
Recruiting
Phase 2
Prevent Cardiac Surgery Associated AKI Trial
SurgeryCoronary Artery DiseaseRenal Failure
George Washington University242 enrolled1 locationNCT06620523
Recruiting
Phase 2
Study of Sivelestat Sodium in OPCABG
Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)
Affiliated Hospital of Nantong University62 enrolled1 locationNCT07118930
Recruiting
Phase 2
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Coronary Artery DiseaseRefractory Angina
XyloCor Therapeutics, Inc.106 enrolled1 locationNCT07048808
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting
Phase 2
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Heart FailureMyocardial InjuryCoronary Artery Disease+1 more
Ralf Rothoerl36 enrolled1 locationNCT06705023
Recruiting
Phase 2
PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
Coronary DiseaseBleedingCoronary Artery Disease+5 more
Federal University of São Paulo120 enrolled1 locationNCT06542393
Completed
Phase 2
Safety and Activity of Oral HPBCD in Coronary Artery Disease
Coronary Artery Disease
PPD part of Thermo Fisher10 enrolled1 locationACTRN12622001377729
Completed
Phase 2
COCOMO-ACS Study: The Colchicine for coronary plaque modification in Acute Coronary Syndrome Study
Acute Coronary SyndromeCoronary Artery Disease
South Australian Health and Medical Research Insititute64 enrolled9 locationsACTRN12618000809235
Recruiting
Phase 2Phase 3
LoDoCo - VRIC Low Dose Colchicine in stable coronary artery disease, Vascular Reactivity and the Inflammatory Cascade.
Coronary Artery Disease
Pfizer Cardiovascular Lipid Research Grant40 enrolled1 locationACTRN12610000397011
Recruiting
Phase 2
A Randomized, Double-Blind, Placebo-Controlled study to determine the safety and tolerability of E5555, and its Effects on Markers of Inflammation in Subjects with Coronary Artery Disease
Coronary Artery Disease
Eisai Limited600 enrolled2 locationsACTRN12607000541404